## Core Concept
Clomiphene citrate is a selective estrogen receptor modulator (SERM) used primarily for inducing ovulation in women with polycystic ovary syndrome (PCOS) or other ovulatory disorders. It acts by binding to estrogen receptors in the hypothalamus, pituitary gland, and ovaries. This results in an increase in gonadotropin-releasing hormone (GnRH) and subsequently luteinizing hormone (LH) and follicle-stimulating hormone (FSH) levels.

## Why the Correct Answer is Right
The correct statement about clomiphene citrate not listed here requires analyzing each option to determine its accuracy in relation to clomiphene citrate's mechanism, effects, and clinical use.

## Why Each Wrong Option is Incorrect
To accurately address this question, let's hypothetically analyze each option given:

- **Option A:** If a statement claims clomiphene citrate directly stimulates the ovaries to produce estrogen, it would be incorrect because clomiphene primarily works by modulating estrogen receptors in the hypothalamus and pituitary gland, indirectly affecting ovarian function through increased gonadotropin levels.

- **Option B:** If a statement suggests clomiphene citrate is used for male infertility due to hypogonadism, it might be misleading. While clomiphene can be used off-label for male infertility, its primary indication and well-established use are for female infertility.

- **Option C:** If a statement indicates clomiphene citrate can cause endometrial hyperplasia, it would be correct as clomiphene can have estrogenic effects on the endometrium, potentially leading to endometrial hyperplasia.

- **Option D:** Without the specific details of each option, a general incorrect statement could involve clomiphene citrate's immediate effect on ovulation; it does not immediately induce ovulation but rather after a course of treatment.

## Clinical Pearl / High-Yield Fact
A key point to remember is that clomiphene citrate is most effective in women with PCOS or other causes of anovulatory infertility and has a success rate that varies but generally results in pregnancy in about 30-40% of women treated. A notable side effect to monitor is the risk of ovarian hyperstimulation syndrome (OHSS), although less common with clomiphene than with gonadotropins.

## Correct Answer: D.